Resumen

MONSALVE MEJIA, Germán; RODRIGUEZ FRAILE, José Ramón  y  VASCO RAMIREZ, Mauricio. Monitoría hemodinámica no invasiva en Síndrome Hellp. Rev. colomb. anestesiol. [online]. 2006, vol.34, n.2, pp.129-132. ISSN 0120-3347.

The HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a serious complication that affects around 10% pregnancies with severe preeclampsia-eclampsia [1]. Most of the patients with a diagnosis of HELLP syndrome come to light after 27 weeks’ gestation. When the cardiovascular system compromise is severe, the invasive monitoring is frequent in order to make a guided therapeutic and reduce the complications. Albeit the use of the pulmonary artery catheter is reported in patients with severe preeclampsia and associated HELLP syndrome with serious cardiovascular compromise and refractory oliguria, there is a risk of mayor complications associated with central punctures in these patients with severe thrombocytopenia [2]. The HEMOSONIC 100 (Arrow International, Reading, PA) uses transesophageal Doppler ultrasound to measure the aortic blood flow in a non-invasive way and beat by beat in real time. We report the use of HEMOSONIC 100 during the cesarean section of a patient with HELLP syndrome in order to optimize the intraoperatory cardiovascular management.

Palabras clave : Pregnancy Complications; Monitoring Physiologic; HELLP Syndrome.

        · resumen en Español     · texto en Español     · Español ( pdf )